-
-
Call more information
660-596-2224 -
Authors Judy George, Shannon Firth, and Kristina Fiore, MedPage Today Staff — Nearly 5% of those who responded to a bi-weekly MedPage Today survey have or had the disease Of 763 respondents in a MedPage Today survey — 86% of whom were physicians — 4.91% reported they had or currently have COVID-19. The findings come from […]
Read MoreAuthor: John Anderer Study Fines Author: “There are very few situations where a model perfectly corresponds with reality. By definition, models are simplified from reality. In some way or another, all models are wrong.” It’s proven incredibly difficult for scientists, organizations, and governments alike to accurately predict the spread of COVID-19 through countries and communities. Now, however, […]
Read MoreAuthor: Kristin J. Kelley The FDA has approved the sodium-glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin (Farxiga) to lower the risk for cardiovascular death and heart failure hospitalization in patients with heart failure with reduced ejection fraction. The indication is for adults, regardless of whether they have type 2 diabetes. Approval was based on results from […]
Read MoreAuthors: Laura E. Wong, MD, PhD et al NEJM Catalyst Leaders at a 150-bed community hospital in California partnered with a collective of human-centered designers to rapidly address a sudden drop in emergency department visits after a statewide stay-at-home order was issued. The initiative developed targeted messaging to assuage patient fears about safety and remind […]
Read MoreBy Amy Orciari Herman Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS Some 9% of adults who underwent hepatitis C virus (HCV) screening at four U.S. emergency departments that adopted universal screening had positive antibody results, according to an MMWR study. Researchers studied EDs in Alabama, California, Maryland, and Massachusetts that offered universal HCV antibody […]
Read More